Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusion Requirements in Ugandan Children with Sickle Cell Anemia: Baseline Data from the Alternative Dosing and Prevention of Transfusions (ADAPT) Trial

Alexandra Power-Hays, Ruth Namazzi, Charles Kato, Andrea Conroy, Heather Ann Hume, Chandy C. John, Susan E. Stuber, Adam C. Lane, Teresa S. Latham, Robert Opoka, Russell E. Ware

Blood (2023) 142 (Supplement 1): 1156.

https://doi.org/10.1182/blood-2023-181058

Published: 2023

Journal Articles

Effects of L-Glutamine on Biomarkers of Response in Sickle Cell Disease: A Pharmacokinetics-Pharmacodynamics Analysis

Alina Sadaf, Min Dong, Jennifer Korpik, Amanda Pfeiffer, Theodosia A. Kalfa, Teresa S. Latham, Alexander A. Vinks, Russell E. Ware, Charles T. Quinn

Blood (2023) 142 (Supplement 1): 1145.

https://doi.org/10.1182/blood-2023-180312

Published: 2023

Journal Articles

Hydroxyurea Improves Intelligence Quotient Scores in Children with Sickle Cell Anemia and Elevated Transcranial Doppler Velocity

Angela E Rankine-Mullings, Deanne Soares, Karen Aldred, Susan Chang-Lopez, Margaret Elizabeth Wisdom-Phipps, William Schultz, Teresa S. Latham, Susan E. Stuber, Patrice Jackson, Russell E. Ware, Marvin Ellsworth Reid

Blood (2023) 142 (Supplement 1): 797.

https://doi.org/10.1182/blood-2023-188160

Published: 2023

Journal Articles

Hydroxyurea Dose Optimization Is Safe and Improves Outcomes for Children with Sickle Cell Anemia Living in Sub-Saharan Africa: The Reach Experience

Banu Aygun, Adam C. Lane, Luke R. Smart, Leon Tshilolo, Thomas N. Williams, Peter Olupot-Olupot, Brigida Santos, Susan E. Stuber, George A. Tomlinson, Teresa S. Latham, Russell E. Ware

Blood (2023) 142 (Supplement 1): 6.

https://doi.org/10.1182/blood-2023-172919

Published: 2023

Journal Articles

Prospective Identification of Variables As Outcomes for Treatment (PIVOT): A Phase II Clinical Trial of Hydroxyurea for Children and Adults with HbSC Disease

Catherine I. Segbefia, Luke R. Smart, Susan E. Stuber, Priscilla Ekpale, Kwesi N. Amissah-Arthur, Klenam Dzefi-Tettey, Enoch Mensah, Adam C. Lane, Diana Dwuma-Badu, Teresa S. Latham, Yvonne Dei-Adomakoh, Russell E. Ware

Blood (2023) 142 (Supplement 1): 3877.

https://doi.org/10.1182/blood-2023-190351

Published: 2023

Journal Articles

Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa

Peter Olupot-Olupot, George Tomlinson, Thomas N. Williams, Léon Tshilolo, Brígida Santos, Luke R. Smart, Kathryn McElhinney, Thad A. Howard, Banu Aygun, Susan E. Stuber, Adam Lane, Teresa S. Latham, Russell E. Ware

Blood (2023) 141 (12): 1402–1410.

https://doi.org/10.1182/blood.2022017051

Published: 2023

Includes: Supplemental data

Journal Articles

Effects of Hydroxyurea Treatment on Malaria Infections in Sub-Saharan Africa

Peter Olupot-Olupot, George A. Tomlinson, PhD BSc, MSc, Teresa S. Latham, MA, Patrick T. McGann, MD, Brigida Santos, Banu Aygun, MD, Susan Stuber, MA, Leon Tshilolo, MD PhD, Adam Lane, PhD, Thomas N. Williams, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 522.

https://doi.org/10.1182/blood-2019-129251

Published: 2019

Journal Articles

Stroke Avoidance for Children in República Dominicana (SACRED):a Prospective Trial to Reduce Stroke in Children with Sickle Cell Anemia

Luisanna Sanchez, MD, Rosa M. Nieves, MD, Teresa S. Latham, MA, Adam Lane, PhD, Neelum Jeste, MD, Gabriela S. Urcuyo, MD, Melissa E. Berges, MD, Carla Florencio, MD, Carla Gonzalez, MD, Paola Del Villar, MD, Janet Adams, Susan Stuber, MA, William Schultz, M.H.S., Rafael Mena, MD, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 2285.

https://doi.org/10.1182/blood-2019-130214

Published: 2019

Journal Articles

Splenomegaly in Children with Sickle Cell Anemia Receiving Hydroxyurea in Sub-Saharan Africa

Leon Tshilolo, MD PhD, George A. Tomlinson, PhD BSc, MSc, Patrick T. McGann, MD, Teresa S. Latham, MA, Peter Olupot-Olupot, Brigida Santos, Banu Aygun, MD, Susan Stuber, MA, Adam Lane, PhD, Thomas N. Williams, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 993.

https://doi.org/10.1182/blood-2019-129937

Published: 2019

Journal Articles

Genetic Analysis in the Tanzania Sickle Surveillance Study (TS3): Modifiers of Sickle Cell Disease and Identification of Hemoglobin Variants

Luke R. Smart, MD, Emmanuela E. Ambrose, MD, Mwesige Charles, BScHLS, Arielle G. Hernandez, MPH, Teresa S. Latham, MA, Adolfine Hokororo, MD MMed, MSc, Medard Beyanga, BLS, MSc, Erasmus Kamugisha, MD MSc, PhD, Erius Tebuka, MD MMed, Thad A. Howard, MS, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 988.

https://doi.org/10.1182/blood-2019-128554

Published: 2019

Journal Articles

Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia

Robert O. Opoka, Christopher M. Ndugwa, Teresa S. Latham, Adam Lane, Heather A. Hume, Phillip Kasirye, James S. Hodges, Russell E. Ware, Chandy C. John

Blood (2017) 130 (24): 2585–2593.

https://doi.org/10.1182/blood-2017-06-788935

Published: 2017

Journal Articles

Novel Use of Hydroxyurea in an African Region with Malaria (NOHARM): A Randomized Controlled Trial

Robert Opoka, Christopher Ndugwa, MMED, Teresa S. Latham, Adam Lane, Heather Ann Hume, MDFRCPC, Philip Kasirye, MD, James L Hodges, PhD, Russell E. Ware, MD PhD, Chandy C John, MD

Blood (2017) 130 (Supplement 1): 759.

https://doi.org/10.1182/blood.V130.Suppl_1.759.759

Published: 2017

Journal Articles

Pharmacokinetics of Hydroxyurea Therapy in African Children with Sickle Cell Anemia:Â Noharm Ancillary PK Study

Anu Marahatta, PhD, Min Dong, PhD, Robert Opoka, Kathryn E. McElhinney, Teresa S. Latham, Chandy C. John, MDMS, Alexander A. Vinks, Russell E. Ware, MD PhD

Blood (2017) 130 (Supplement 1): 2252.

https://doi.org/10.1182/blood.V130.Suppl_1.2252.2252

Published: 2017

NARROW

Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusion Requirements in Ugandan Children with Sickle Cell Anemia: Baseline Data from the Alternative Dosing and Prevention of Transfusions (ADAPT) Trial

Effects of L-Glutamine on Biomarkers of Response in Sickle Cell Disease: A Pharmacokinetics-Pharmacodynamics Analysis

Hydroxyurea Improves Intelligence Quotient Scores in Children with Sickle Cell Anemia and Elevated Transcranial Doppler Velocity

Hydroxyurea Dose Optimization Is Safe and Improves Outcomes for Children with Sickle Cell Anemia Living in Sub-Saharan Africa: The Reach Experience

Prospective Identification of Variables As Outcomes for Treatment (PIVOT): A Phase II Clinical Trial of Hydroxyurea for Children and Adults with HbSC Disease

Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa

Effects of Hydroxyurea Treatment on Malaria Infections in Sub-Saharan Africa

Stroke Avoidance for Children in República Dominicana (SACRED):a Prospective Trial to Reduce Stroke in Children with Sickle Cell Anemia

Splenomegaly in Children with Sickle Cell Anemia Receiving Hydroxyurea in Sub-Saharan Africa

Genetic Analysis in the Tanzania Sickle Surveillance Study (TS3): Modifiers of Sickle Cell Disease and Identification of Hemoglobin Variants

Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia

Novel Use of Hydroxyurea in an African Region with Malaria (NOHARM): A Randomized Controlled Trial

Pharmacokinetics of Hydroxyurea Therapy in African Children with Sickle Cell Anemia:Â Noharm Ancillary PK Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only